Long Daniel D., SVP, DD, reported an open-market or private sale at Septerna, Inc. involving 3333.000000 shares for an estimated $126077.72. Reported holdings after the transaction were 96412.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
SVP, Drug Discovery
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 20, 2026.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.34 to $38.21. The Reporting Person undertakes to provide to the Iss…
1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 1, 2024, subject to the Reporting Person'…
0 other filings
0 recent txs